PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA
Clinical trials for PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for teens battling rare chest cancer
Disease control CompletedThis trial tested whether adding the drug rituximab to standard chemotherapy could help children and teenagers with a rare type of chest lymphoma. It involved 47 young patients aged 6 months to 18 years who had not yet received treatment. The main goal was to see if this combinat…
Matched conditions: PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Experimental 'Living Drug' tested as last hope for tough lymphomas
Disease control CompletedThis study tested a new type of personalized immune therapy called BZ019 (a CAR-T cell therapy) in adults with aggressive B-cell lymphomas that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the therapy could shrink t…
Matched conditions: PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC